Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
Introduction: The Coronavirus disease-2019 (COVID-19) pandemic that started over two years ago has led to high mortality and morbidity. Vaccine studies have been initiated worldwide to end the pandemic, and the CoronaVac® vaccine was first administered to healthcare workers at high risk of COVID-19...
Main Authors: | Ayşin KILINÇ TOKER, Duygu ÇERÇİOĞLU ÖZDEMİR, Esma EREN, Ayşe TURUNÇ ÖZDEMİR, Azade KANAT, İlhami ÇELİK, İbrahim TOKER |
---|---|
Format: | Article |
Language: | Turkish |
Published: |
Galenos Yayinevi
2022-05-01
|
Series: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
Subjects: | |
Online Access: | http://mjima.org/text.php?&id=322 |
Similar Items
-
Seroprevalence of SARS COV-2 anti-nucleocapsid antibodies in Turkish healthcare workers before vaccination schedule: January 2021
by: Ayşin Kılınç Toker, et al.
Published: (2022-06-01) -
Clinical characteristics of patients hospitalized for COVID-19 vaccinated with at least two doses in a tertiary care hospital in Turkey
by: Ayşin Kılınç Toker, et al.
Published: (2022-09-01) -
The Outcomes of Direct-acting Antiviral Treatment in 177 Patients with Hepatitis C Virus: A Single-center Experience
by: Ayşin KILINÇ TOKER, et al.
Published: (2023-12-01) -
The value of C-reactive protein velocity (CRPv) on mortality in sepsis patients who are emergently hospitalized in the ICU: A retrospective single-center study
by: Ayşin Kılınç Toker, et al.
Published: (2024-10-01) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
by: Samar Samoud, et al.
Published: (2023-08-01)